eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Share:
Share:
Original paper

Relationship between uric acid to HDL ratio and extent and severity of coronary artery disease

Mehmet Yaman
1
,
Ali Y. Kilinc
2
,
Fatih Öztürk
1
,
Mehmet Coşkun
3
,
Ramazan Duz
4
,
Yilmaz Gunes
3

  1. Cardiology Department, Echomar Hospital, Zonguldak, Turkey
  2. Department of Cardiology, Haseki Training and Research Hospital, Istanbul, Turkey
  3. Cardiology Department, Bolu Abant Izzet Baysal University, Bolu, Turkey
  4. Cardiology Department, Van Yuzuncuyıl University, Van, Turkey
Adv Interv Cardiol
Online publish date: 2024/11/14
Article file
- relationship between.pdf  [0.09 MB]
Get citation
 
 
1. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-57.
2. Onat A, Yazici M, Sari I, et al. The risk factor survey of 2003 in western Turkey indicates trend to declining coronary mortality and urban overall mortality. Arch Turk Soc Cardiol 2003; 31: 762-9.
3. Lusis AJ. Atherosclerosis. Nature 2000; 6801: 233-41.
4. Davies MJ. The pathophysiology of acute coronary syndromes. Heart 2000; 83: 361-6.
5. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1: 219-27.
6. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606-98.
7. Navab M, Reddy ST, Van Lenten BJ, et al. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol 2011; 8: 222-32.
8. Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet 2012; 380: 572-80.
9. Maiuolo J, Oppedisano F, Gratteri S, et al. Regulation of uric acid metabolism and excretion. Int J Cardiol 2016; 213: 8-14.
10. Fenech G, Rajzbaum G, Mazighi M, et al. Serum uric acid and cardiovascular risk: state of the art and perspectives. Joint Bone Spine 2014; 81: 392-7.
11. Ndrepepa G. Uric acid and cardiovascular disease. Clin Chim Acta 2018; 484: 150-63.
12. Xiong Z, Zhu C, Qian X, et al. Predictors of clinical SYNTAX score in coronary artery disease: serum uric acid, smoking, and Framingham risk stratification. J Invasive Cardiol 2011; 23: 501-4.
13. Kimura Y, Tsukui D, Kono H. Uric acid in inflammation and the pathogenesis of atherosclerosis. Int J Mol Sci 2021; 22: 12394.
14. Kurtkulagi O, Tel BMA, Kahveci G, et al. Hashimoto’s thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio. Rom J Intern Med 2021; 59: 403-8.
15. Aktas G, Kocak MZ, Bilgin S, et al. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male 2020; 23: 1098-102.
16. Park B, Jung DH, Lee YJ. Predictive value of serum uric acid to HDL cholesterol ratio for incident ischemic heart disease in non-diabetic Koreans. Biomedicines 2022; 10: 1422.
17. Knuuti J, Wijns W, Saraste A, et al. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020; 41: 407-77.
18. Rampidis GP, Benetos G, Benz DC, et al. A guide for Gensini Score calculation. Atherosclerosis 2019; 287: 181-3.
19. Sinning C, Lillpopp L, Appelbaum S, et al. Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application. Clin Res Cardiol 2013; 102: 495-503.
20. Kocak MZ, Aktas G, Erkus E, et al. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras 2019; 65: 9-15.
21. Yazdi F, Baghaei MH, Baniasad A, et al. Investigating the relationship between serum uric acid to high-density lipoprotein ratio and metabolic syndrome. Endocrinol Diabetes Metab 2022; 5: e00311.
22. Uzeli U, Doğan AG. The relationship between diabetic neuropathy and uric acid/high-density lipoprotein ratio in patients with type-2 diabetes mellitus. Cureus 2023; 5: e45151.
23. Di Bonito P, Rosanio FM, Marcovecchio ML, et al. Uric acid and cardiometabolic risk by gender in youth with type 1 diabetes. Sci Rep 2022; 12: 12153.
24. Lee SW, Kim HC, Nam C, et al. Age-differential association between serum uric acid and incident hypertension. Hypertens Res 2019; 42: 428-37.
25. Zhou X, Xu J. Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus. J Diabetes Investig 2024; 15: 113-20.
26. Li F, Zhao D, Li Q, et al. Uric acid to high-density lipoprotein cholesterol ratio is a novel marker to predict functionally significant coronary artery stenosis. J Interv Cardiol 2022; 2022: 9057832.
27. Yang Y, Zhang J, Jia L, et al. The interaction between uric acid and high-density lipoprotein cholesterol on the prognosis of patients with acute myocardial infarction. Front Cardiovasc Med 2023; 10: 1226108.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.